Cubist Systematic Strategies, LLC Zai Lab LTD Transaction History
Cubist Systematic Strategies, LLC
- $15.6 Billion
- Q1 2025
A detailed history of Cubist Systematic Strategies, LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 93,645 shares of ZLAB stock, worth $2.82 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
93,645
Previous 72,619
28.95%
Holding current value
$2.82 Million
Previous $1.9 Million
78.01%
% of portfolio
0.02%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding ZLAB
# of Institutions
175Shares Held
52.2MCall Options Held
92.9KPut Options Held
318K-
Capital World Investors Los Angeles, CA6.01MShares$181 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X03.81MShares$115 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.65MShares$110 Million0.03% of portfolio
-
Clearbridge Investments, LLC New York, NY3.28MShares$98.8 Million0.11% of portfolio
-
Rtw Investments, LP New York, NY3.14MShares$94.5 Million1.86% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $2.95B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...